CalciMedica Announces Publication of Results from CARDEA COVID-19 Study in Critical Care
– Results further support therapeutic potential of Auxora in respiratory diseases and other inflammatory diseases – LA JOLLA, Calif., April 14, 2022 – CalciMedica Inc. (CalciMedica or the Company), the CRAC (calcium release-activated calcium) channel company, today announced the publication of results from the Company’s CARDEA clinical trial, a Phase 2 trial of Auxora in severe COVID-19 …
CalciMedica Announces Publication of Results from CARDEA COVID-19 Study in Critical Care Read More »